{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:52:58Z","timestamp":1781783578222,"version":"3.54.5"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","award":["99105"],"award-info":[{"award-number":["99105"]}],"id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113557","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T13:51:03Z","timestamp":1663163463000},"page":"113557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach"],"prefix":"10.1016","volume":"155","author":[{"given":"Hossein","family":"Tarrahimofrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Darvish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2022.113557_bib2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10482-020-01448-9","article-title":"Expanding the host range: infection of a reptilian host (Furcifer pardalis) by an atypical Brucella strain","volume":"113","author":"Eisenberg","year":"2020","journal-title":"Antonie Van. Leeuwenhoek"},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib4","article-title":"Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella species","volume":"14","author":"Waldrop","year":"2019"},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ygeno.2019.10.009","article-title":"Potential druggable proteins and chimeric vaccine construct prioritization against Brucella melitensis from species core genome data","volume":"112","author":"Aslam","year":"2020","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jinf.2017.01.011","article-title":"<em>Brucella<\/em> endocarditis: clinical features and treatment outcomes of 10 cases from Xinjiang, China","volume":"74","author":"Jia","year":"2017","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib7","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/s41598-019-40084-w","article-title":"The immunogenicity of OMP31 peptides and its protection against brucella melitensis infection in mice","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113557_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cimid.2019.03.015","article-title":"Immunogenic and protective antigens of Brucella as vaccine candidates","volume":"65","author":"Masjedian Jezi","year":"2019","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib9","first-page":"957","article-title":"Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB\/c mice","volume":"21","author":"Shojaei","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2022.113557_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104318","article-title":"Bioinformatics analysis of candidate proteins Omp2b, P39 and BLS for Brucella multivalent epitope vaccines","volume":"147","author":"Sha","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biopha.2022.113557_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.molimm.2019.09.013","article-title":"Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella","volume":"114","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/14760584.2022.2021882","article-title":"Exploring Klebsiella pneumoniae capsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia","volume":"21","author":"Dey","year":"2022","journal-title":"Expert Rev. Vaccin."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9091038","article-title":"Development of a conserved chimeric vaccine for induction of strong immune response against staphylococcus aureus using immunoinformatics approaches","volume":"9","author":"Chatterjee","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2022.113557_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105171","article-title":"B and T cell epitope-based peptides predicted from clumping factor protein of Staphylococcus aureus as vaccine targets","volume":"160","author":"Dey","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biopha.2022.113557_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2016.04.016","article-title":"A novel recombinant multi-epitope protein against Brucella melitensis infection","volume":"175","author":"Yin","year":"2016","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib16","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1038\/s41598-019-41496-4","article-title":"Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa","volume":"9","author":"Solanki","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib17","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","article-title":"In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases","volume":"9","author":"Shey","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113557_bib18","first-page":"1","article-title":"Immunoinformatic approach employing modeling and simulation to design a novel vaccine construct targeting MDR efflux pumps to confer wide protection against typhoidal Salmonella serovars","author":"Mahapatra","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13099-022-00495-z","article-title":"Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium","volume":"14","author":"Dey","year":"2022","journal-title":"Gut Pathog."},{"issue":"28","key":"10.1016\/j.biopha.2022.113557_bib20","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1016\/j.vaccine.2018.05.106","article-title":"Multi-epitope DnaK peptide vaccine against S.Typhi: an in silico approach","volume":"36","author":"Verma","year":"2018","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.biopha.2022.113557_bib21","doi-asserted-by":"crossref","first-page":"9892","DOI":"10.1074\/jbc.M805458200","article-title":"<em>Brucella<\/em> TIR domain-containing protein mimics properties of the toll-like receptor adaptor protein TIRAP *","volume":"284","author":"Radhakrishnan","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0040021","article-title":"Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1","volume":"4","author":"Salcedo","year":"2008","journal-title":"PLOS Pathog."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007979","article-title":"The TIR-domain containing effectors BtpA and BtpB from Brucella abortus impact NAD metabolism","volume":"16","author":"Coronas-Serna","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2022.113557_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2859-5-13","article-title":"Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system","volume":"5","author":"Cardoso","year":"2006","journal-title":"Micro Cell Fact."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/cdli.3.4.472-476.1996","article-title":"Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9","volume":"3","author":"Baldi","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib26","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1128\/IAI.67.9.4960-4962.1999","article-title":"Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins","volume":"67","author":"Tibor","year":"1999","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib27","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/iai.62.9.3633-3639.1994","article-title":"Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins","volume":"62","author":"Tibor","year":"1994","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.biopha.2022.113557_bib28","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.173.7.4635","article-title":"Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus","volume":"173","author":"Giambartolomei","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1286-4579(00)00317-8","article-title":"Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies","volume":"2","author":"Bowden","year":"2000","journal-title":"Microbes Infect."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib30","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.0902209","volume":"184","author":"Pasquevich","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib31","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/s41598-018-37668-3","article-title":"MapB, the Brucella suis TamB homologue, is involved in cell envelope biogenesis, cell division and virulence","volume":"9","author":"Bialer","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12275-020-0144-y","article-title":"Omp16, a conserved peptidoglycan-associated lipoprotein, is involved in Brucella virulence in vitro","volume":"58","author":"Zhi","year":"2020","journal-title":"J. Microbiol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1586\/erv.11.110","article-title":"Confronting the barriers to develop novel vaccines against brucellosis","volume":"10","author":"Oliveira","year":"2011","journal-title":"Expert Rev. Vaccin."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034246","article-title":"Characterization of periplasmic protein BP26 epitopes of brucella melitensis reacting with murine monoclonal and sheep antibodies","volume":"7","author":"Qiu","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2022.113557_bib35","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/IAI.05289-11","article-title":"Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection","volume":"79","author":"Oliveira","year":"2011","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.biopha.2022.113557_bib36","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1074\/jbc.M010399200","article-title":"SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity","volume":"276","author":"Vig","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113557_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fvets.2020.00576","article-title":"Comparison of immune effects between brucella recombinant Omp10-Omp28-L7\/L12 proteins expressed in eukaryotic and prokaryotic systems","volume":"7","author":"Zhu","year":"2020","journal-title":"Front. Vet. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7883\/yoken.JJID.2017.019","article-title":"Comparative analysis of immune responses to outer membrane antigens OMP10, OMP19, and OMP28 of brucella abortus","volume":"71","author":"Im","year":"2018","journal-title":"Jpn. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4142\/jvs.2012.13.3.287","article-title":"Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice","volume":"13","author":"Lim","year":"2012","journal-title":"J. Vet. Sci."},{"issue":"Pt 4","key":"10.1016\/j.biopha.2022.113557_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1099\/jmm.0.017566-0","article-title":"Cloning and expression of the immunoreactive Brucella melitensis 28 kDa outer-membrane protein (Omp28) encoding gene and evaluation of the potential of Omp28 for clinical diagnosis of brucellosis","volume":"59","author":"Thavaselvam","year":"2010","journal-title":"J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113557_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa002","article-title":"A combined subunit vaccine comprising BP26, Omp25 and L7\/L12 against brucellosis","volume":"77","author":"Gupta","year":"2019","journal-title":"Pathog. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2022.113557_bib42","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/IAI.69.8.4823-4830.2001","article-title":"Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages","volume":"69","author":"Jubier-Maurin","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.1996.tb08547.x","article-title":"Molecular and immunological characterization of the major outer membrane proteins of Brucella","volume":"145","author":"Cloeckaert","year":"1996","journal-title":"FEMS Microbiol. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8050766","article-title":"Proteomics of brucella: technologies and their applications for basic research and medical microbiology","volume":"8","author":"Wareth","year":"2020","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.biopha.2022.113557_bib45","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4049\/jimmunol.156.8.2885","article-title":"Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells","volume":"156","author":"Caron","year":"1996","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib46","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1128\/IAI.67.9.4960-4962.1999","article-title":"Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins","volume":"67","author":"Tibor","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12917-019-2074-7","article-title":"In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB\/c mice","volume":"15","author":"Nazifi","year":"2019","journal-title":"BMC Vet. Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib48","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.biopha.2022.113557_bib49","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib50","first-page":"957","article-title":"Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB\/c mice","volume":"21","author":"Shojaei","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113557_bib51","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1128\/IAI.69.11.7020-7028.2001","article-title":"Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species","volume":"69","author":"Vizcaino","year":"2001","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib52","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/iai.64.9.3744-3751.1996","article-title":"Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein","volume":"64","author":"Vizcaino","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2022.113557_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2015.00072","article-title":"Type IV secretion system of Brucella spp. and its effectors","volume":"5","author":"Ke","year":"2015","journal-title":"Front. Cell Infect. Microbiol"},{"issue":"7497","key":"10.1016\/j.biopha.2022.113557_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature13081","article-title":"Structure of a type IV secretion system","volume":"508","author":"Low","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CVI.00374-07","article-title":"VirB12 Is a serological marker of <em>brucella<\/em> infection in experimental and natural hosts","volume":"15","author":"Rol\u00e1n","year":"2008","journal-title":"Clin. Vaccin. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib56","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrmicro2218","article-title":"The structural biology of type IV secretion systems","volume":"7","author":"Fronzes","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"24","key":"10.1016\/j.biopha.2022.113557_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413637","article-title":"The VirB system plays a crucial role in brucella intracellular infection","volume":"22","author":"Xiong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2022.113557_bib58","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.febslet.2015.05.051","article-title":"VirB6 and VirB10 from the Brucella type IV secretion system interact via the N-terminal periplasmic domain of VirB6","volume":"589","author":"Villamil Giraldo","year":"2015","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.biopha.2022.113557_bib59","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.0408927102","article-title":"Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis and ComB10 from Helicobacter pylori","volume":"102","author":"Terradot","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2022.113557_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev-biochem-062911-102821","article-title":"Structural biology of bacterial type IV secretion systems","volume":"84","author":"Chandran Darbari","year":"2015","journal-title":"Annu. Rev. Biochem."},{"issue":"5911","key":"10.1016\/j.biopha.2022.113557_bib61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.1166101","article-title":"Structure of a type IV secretion system core complex","volume":"323","author":"Fronzes","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113557_bib62","article-title":"Immunogenic response of brucella canisvirB10 and virB11 mutants in a murine model. frontiers in cellular and infection","volume":"2","author":"Palomares","year":"2012","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1462-5822.2001.00102.x","article-title":"Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole","volume":"3","author":"Comerci","year":"2001","journal-title":"Cell. Microbiol."},{"issue":"13","key":"10.1016\/j.biopha.2022.113557_bib64","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/JB.00406-08","article-title":"VirB3 to VirB6 and VirB8 to VirB11, but Not VirB7, are essential for mediating persistence of brucella in the reticuloendothelial system","volume":"190","author":"den Hartigh Andreas","year":"2008","journal-title":"J. Bacteriol."},{"issue":"17","key":"10.1016\/j.biopha.2022.113557_bib65","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/JB.182.17.4849-4855.2000","article-title":"A homologue of an operon required for DNA transfer in agrobacterium is required in brucella abortusfor virulence and intracellular multiplication","volume":"182","author":"Sieira","year":"2000","journal-title":"J. Bacteriol."},{"issue":"45","key":"10.1016\/j.biopha.2022.113557_bib66","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","article-title":"Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: Evaluation of protection in pregnant heifers","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib67","first-page":"659","article-title":"Recombinant L7\/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells","volume":"83","author":"Oliveira","year":"1994","journal-title":"Immunology"},{"issue":"17\u201318","key":"10.1016\/j.biopha.2022.113557_bib68","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0264-410X(97)00140-0","article-title":"Nucleic acid vaccination of Brucella abortus ribosomal L7\/L12 gene elicits immune response","volume":"15","author":"Kurar","year":"1997","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib69","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib70","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2022.113557_bib71","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molimm.2018.10.002","article-title":"Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB\/c mice","volume":"103","author":"Golshani","year":"2018","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib72","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth.1701","article-title":"SignalP 4.0: discriminating signal peptides from transmembrane regions","volume":"8","author":"Petersen","year":"2011","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib73","first-page":"511","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinforma. (Oxf., Engl. )"},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci.: a Publ. Protein Soc."},{"key":"10.1016\/j.biopha.2022.113557_bib75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinforma."},{"issue":"suppl_2","key":"10.1016\/j.biopha.2022.113557_bib77","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In Silico Approach for Predicting Toxicity of Peptides and Proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.biopha.2022.113557_bib79","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.jmedchem.8b01583","article-title":"Structural basis of TLR2\/TLR1 activation by the synthetic agonist diprovocim","volume":"62","author":"Su","year":"2019","journal-title":"J. Med. Chem."},{"issue":"48","key":"10.1016\/j.biopha.2022.113557_bib80","doi-asserted-by":"crossref","first-page":"40611","DOI":"10.1074\/jbc.M112.404608","article-title":"Structural analyses of human toll-like receptor 4 polymorphisms D299G and T399I *","volume":"287","author":"Ohto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113557_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"41","key":"10.1016\/j.biopha.2022.113557_bib82","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1016\/j.vaccine.2011.05.080","article-title":"Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development","volume":"29","author":"Adams","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biopha.2022.113557_bib83","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"30","key":"10.1016\/j.biopha.2022.113557_bib84","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","article-title":"The advances in brucellosis vaccines","volume":"37","author":"Hou","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12917-019-2074-7","article-title":"In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB\/c mice","volume":"15","author":"Nazifi","year":"2019","journal-title":"BMC Vet. Res"},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biotechadv.2017.03.005","article-title":"Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines","volume":"35","author":"Moyle","year":"2017","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib87","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"issue":"21","key":"10.1016\/j.biopha.2022.113557_bib88","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.febslet.2013.09.007","article-title":"Structure of the Toll\/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA\/Btp1\/TcpB","volume":"587","author":"Kaplan-T\u00fcrk\u00f6z","year":"2013","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib89","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1074\/jbc.M113.523274","article-title":"Mechanism of bacterial interference with TLR4 signaling by <em>brucella<\/em> toll\/interleukin-1 receptor domain-containing protein TcpB *","volume":"289","author":"Alaidarous","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib90","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1128\/IAI.67.9.4960-4962.1999","article-title":"Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. Are lipoproteins","volume":"67","author":"Moore","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12941-017-0182-4","article-title":"Brucella melitensis VirB12 recombinant protein is a potential marker for serodiagnosis of human brucellosis","volume":"16","author":"Mirkalantari","year":"2017","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib92","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1128\/IAI.70.10.5540-5546.2002","article-title":"Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice","volume":"70","author":"Tibor","year":"2002","journal-title":"Infect. Immun."},{"issue":"1\u20134","key":"10.1016\/j.biopha.2022.113557_bib93","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0378-1135(02)00238-9","article-title":"The genome of Brucella melitensis","volume":"90","author":"DelVecchio","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/iai.46.1.188-194.1984","article-title":"Outer membrane proteins from rough strains of four Brucella species","volume":"46","author":"Santos","year":"1984","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1099\/jmm.0.017566-0","article-title":"Cloning and expression of the immunoreactive Brucella melitensis 28\u2005kDa outer-membrane protein (Omp28) encoding geneand evaluation of the potential of Omp28 for clinical diagnosis of brucellosis","volume":"59","author":"Thavaselvam","year":"2010","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113557_bib96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/cdli.4.5.556-564.1997","article-title":"Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay","volume":"4","author":"Letesson","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"42","key":"10.1016\/j.biopha.2022.113557_bib97","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against brucella abortus infection","volume":"77","author":"Pasquevich Karina","year":"2009","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2022.113557_bib99","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/13500872-141-9-2111","article-title":"Restriction site polymorphism of the genes encoding the major 25 kDa and 36 kDa outer-membrane proteins of Brucella","volume":"141","author":"Cloeckaert","year":"1995","journal-title":"Microbiology"},{"key":"10.1016\/j.biopha.2022.113557_bib100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fimmu.2017.00708","article-title":"Brucella Omp25 Upregulates miR-155, miR-21-5p, and miR-23b to inhibit interleukin-12 production via modulation of programmed death-1 signaling in human monocyte\/macrophages","volume":"8","author":"Cui","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-1135(02)00211-0","article-title":"Major outer membrane proteins of Brucella spp.: past, present and future","volume":"90","author":"Cloeckaert","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.biopha.2022.113557_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2017.00197","article-title":"Outer membrane protein 25 of brucella activates mitogen-activated protein kinase signal pathway in human trophoblast cells","volume":"4","author":"Zhang","year":"2017","journal-title":"Front. Vet. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib103","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3892\/etm.2016.3655","article-title":"OMP31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-\u03b1","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes","volume":"25","author":"Commander","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1099\/00222615-47-1-39","article-title":"Evaluation of immunogenicity and protective activity in balb\/c mice of the 25-kDa major outer-membrane protein of brucella melitensis (Omp25) expressed in escherichia coli","volume":"47","author":"Bowden","year":"1998","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113557_bib107","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544","volume":"31","author":"Goel","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1135(02)00110-4","article-title":"Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis","volume":"88","author":"Edmonds","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib109","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.4238\/2015.October.5.10","article-title":"Immunological characteristics of outer membrane protein omp31 of goat Brucella and its monoclonal antibody","volume":"14","author":"Zheng","year":"2015","journal-title":"Genet. Mol. Res.: GMR"},{"issue":"12","key":"10.1016\/j.biopha.2022.113557_bib110","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/CVI.00527-14","article-title":"Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against brucella canis in BALB\/c mice","volume":"21","author":"Clausse","year":"2014","journal-title":"Clin. Vaccin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12866-017-1025-3","article-title":"Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies","volume":"17","author":"Li","year":"2017","journal-title":"BMC Microbiol."},{"issue":"34","key":"10.1016\/j.biopha.2022.113557_bib112","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1073\/pnas.1400478111","article-title":"Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants","volume":"111","author":"Maisonneuve","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113557_bib113","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1042\/BST0350833","article-title":"Targeting the MHC II presentation pathway in allergy vaccine development","volume":"35","author":"Rhyner","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2022.113557_bib114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: An in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.biopha.2022.113557_bib115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","article-title":"Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches","volume":"62","author":"Nezafat","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113557_bib116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijbiomac.2019.08.259","article-title":"Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches","volume":"141","author":"Rahmani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113557_bib117","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2022.113557_bib118","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0300-9475.2004.01442.x","article-title":"Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine","volume":"60","author":"Wang","year":"2004","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113557_bib120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11095-008-9767-0","article-title":"Insertion of the designed helical linker led to increased expression of tf-based fusion proteins","volume":"26","author":"Amet","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113557_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.sajb.2022.04.043","article-title":"The potential of plant-derived secondary metabolites as novel drug candidate against Klebsiella pneumoniae: molecular docking and simulation investigation","author":"Mahapatra","year":"2022","journal-title":"South Afr. J. Bot."},{"issue":"42","key":"10.1016\/j.biopha.2022.113557_bib122","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1016\/j.vaccine.2021.09.025","article-title":"Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection","volume":"39","author":"Mahapatra","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2022.113557_bib123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10989-021-10356-z","article-title":"Molecular characterization and designing of a novel multiepitope vaccine construct against pseudomonas aeruginosa","volume":"28","author":"Dey","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2022.113557_bib124","first-page":"8","article-title":"Genome-based identification and comparative analysis of enzymes for carotenoid biosynthesis in microalgae","volume":"38","author":"Narang","year":"2021"},{"key":"10.1016\/j.biopha.2022.113557_bib125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2018.04.002","article-title":"Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model","volume":"99","author":"Paul","year":"2018","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113557_bib126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin. Vaccin. Immunol. CVI"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.113557_bib127","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.vetmic.2004.05.004","article-title":"Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis","volume":"102","author":"Estein","year":"2004","journal-title":"Vet. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:16:40Z","timestamp":1781781400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222009465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":127,"alternative-id":["S0753332222009465"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113557","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113557"}}